Does impaired endogenous thrombolysis in acute coronary syndrome patients predict cardiovascular death and nonfatal myocardial infarction?
Assessment of endogenous thrombolytic status based on the lysis of platelet-rich thrombi from native blood using the point-of-care GTT can identify ACS patients at risk of future cardiac events.
Our findings illustrate the benefits for patients of specific and actionable organizational practices that provide and reinforce compassion.